Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: Beneficial Effect of Silymarin in Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the beneficial effect of silymarin in Ulcerative Colitis is currently recruiting. Sponsored by Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silymarin (silymarin)

Snippet

Sponsor: Tanta University | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING